Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Accumulated Expenses (2016 - 2026)

Healthstream has reported Accumulated Expenses over the past 16 years, most recently at $5.6 million for Q4 2025.

  • Quarterly Accumulated Expenses rose 7.8% to $5.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.6 million through Dec 2025, up 7.8% year-over-year, with the annual reading at $5.6 million for FY2025, 7.8% up from the prior year.
  • Accumulated Expenses was $5.6 million for Q4 2025 at Healthstream, down from $6.6 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $17.4 million in Q3 2024 and troughed at $4.2 million in Q2 2024.
  • The 5-year median for Accumulated Expenses is $5.6 million (2022), against an average of $6.5 million.
  • Year-over-year, Accumulated Expenses crashed 74.97% in 2021 and then soared 153.09% in 2024.
  • A 5-year view of Accumulated Expenses shows it stood at $5.0 million in 2021, then grew by 8.06% to $5.4 million in 2022, then skyrocketed by 74.39% to $9.5 million in 2023, then tumbled by 45.32% to $5.2 million in 2024, then rose by 7.8% to $5.6 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Accumulated Expenses are $5.6 million (Q4 2025), $6.6 million (Q3 2025), and $4.8 million (Q2 2025).